PCA Opportunities Fund 2023, L.P. - Series E (Life Sciences IV) research brief
CIK 2006308
Generated Nov. 2, 2026, 11:13 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: GREENWICH CT. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Jan. 3, 2025 · D/A · 0000950142-25-000025 · Source evidence
Reported offering amount: Unavailable USD. Reported amount sold: 34415000 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “PCA Opportunities Fund 2023, L.P. - Series E (Life Sciences IV) research brief,” CIK 2006308, retrieved Nov. 2, 2026, 11:13 a.m.. Cite the specific accessions used. No amounts have been summed.